Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors

NCT00019630 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Childhood Soft Tissue Sarcoma
Childhood Liver Cancer
Bone Cancer
Brain Tumor
Kidney Tumor

Interventions

DRUG: doxorubicin HCl liposome

Sponsor

National Cancer Institute (NCI)